| __timestamp | Iovance Biotherapeutics, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 9335772 | 22570000 |
| Thursday, January 1, 2015 | 12390000 | 24378000 |
| Friday, January 1, 2016 | 25602000 | 26621000 |
| Sunday, January 1, 2017 | 21262000 | 28653000 |
| Monday, January 1, 2018 | 28430000 | 37734000 |
| Tuesday, January 1, 2019 | 40849000 | 41884000 |
| Wednesday, January 1, 2020 | 60210000 | 64435000 |
| Friday, January 1, 2021 | 83664000 | 57483000 |
| Saturday, January 1, 2022 | 104097000 | 70062000 |
| Sunday, January 1, 2023 | 106916000 | 52790000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing expenses is crucial for sustaining growth and innovation. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Ligand Pharmaceuticals Incorporated and Iovance Biotherapeutics, Inc. over the past decade. From 2014 to 2023, Iovance Biotherapeutics saw a staggering increase of over 1,000% in SG&A expenses, peaking at approximately $107 million in 2023. In contrast, Ligand Pharmaceuticals experienced a more modest growth of around 134%, reaching about $53 million in the same year. This divergence highlights Iovance's aggressive expansion strategy, while Ligand maintains a more conservative approach. Understanding these trends provides valuable insights into each company's operational focus and strategic priorities, offering a glimpse into their future trajectories in the biotech industry.
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.
Neurocrine Biosciences, Inc. and Iovance Biotherapeutics, Inc.: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ligand Pharmaceuticals Incorporated Trends and Insights
Operational Costs Compared: SG&A Analysis of Halozyme Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Cost Management Insights: SG&A Expenses for Opthea Limited and Ligand Pharmaceuticals Incorporated
PTC Therapeutics, Inc. or Ligand Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Amphastar Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Ligand Pharmaceuticals Incorporated vs Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Ligand Pharmaceuticals Incorporated and MiMedx Group, Inc.
Mesoblast Limited or Iovance Biotherapeutics, Inc.: Who Manages SG&A Costs Better?